Treating foot infections in diabetic patients: a randomized, multicenter, open-label trial of linezolid versus ampicillin-sulbactam/amoxicillin-clavulanate (Q34284305)
Jump to navigation
Jump to search
scientific article
- Treating Foot Infections in Diabetic Patients: A Randomized, Multicenter, Open‐Label Trial of Linezolid versus Ampicillin‐Sulbactam/Amoxicillin‐Clavulanate
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Treating foot infections in diabetic patients: a randomized, multicenter, open-label trial of linezolid versus ampicillin-sulbactam/amoxicillin-clavulanate |
scientific article |
|
Statements
1 reference
Treating foot infections in diabetic patients: a randomized, multicenter, open-label trial of linezolid versus ampicillin-sulbactam/amoxicillin-clavulanate (English)
1 reference
Treating Foot Infections in Diabetic Patients: A Randomized, Multicenter, Open‐Label Trial of Linezolid versus Ampicillin‐Sulbactam/Amoxicillin‐Clavulanate (English)
0 references
Benjamin A Lipsky
1 reference
Kamal Itani
1 reference
Carl Norden
1 reference
Linezolid Diabetic Foot Infections Study Group
1 reference
9 December 2003
1 reference
January 2004
0 references
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference